BIOMAT Database Logo BIOMAT Database Logo

A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152. 1998

H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium.

Two mutant virus strains in which the novel P225H mutation appeared in a V106A reverse transcriptase (RT)-mutated genetic background upon treatment of human immunodeficiency virus type 1 (HIV-1) with quinoxaline S-2720 were isolated. Surprisingly, the addition of the P225H mutation to the V106A RT mutant genetic background resensitized the V106A RT mutant virus to the non-nucleoside RT inhibitor (NNRTI) BHAP U-90152, but not to other NNRTIs. Construction of both recombinant viruses and recombinant RTs containing the V106A, P225H and V106A+P225H mutations revealed that P225H was indeed responsible for the marked potentiation of the antiviral activity of BHAP against the P225H single-mutant virus and the V106A+P225H double-mutant virus when compared to wild-type and V106A single-mutant viruses, respectively. An explanation for the markedly increased sensitivity of the P225H mutant HIV-1 RT to BHAP and not to the other NNRTIs was provided by the unique features of the X-ray structure of the RT-BHAP complex.

UI MeSH Term Description Entries
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D006639 Histidine An essential amino acid that is required for the production of HISTAMINE. Histidine, L-isomer,L-Histidine,Histidine, L isomer,L-isomer Histidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D019943 Amino Acid Substitution The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties. Amino Acid Substitutions,Substitution, Amino Acid,Substitutions, Amino Acid
D020008 Delavirdine A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. Delavirdine Mesylate,Rescriptor,U-90152,U-90152S,Mesylate, Delavirdine,U 90152,U 90152S,U90152,U90152S

Related Publications

H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.
May 1993, Antimicrobial agents and chemotherapy,
H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
Sensitivity of (138 Glu-->Lys) mutated human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) to HIV-1-specific RT inhibitors.
June 1994, Biochemical and biophysical research communications,
H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
Human Immunodeficiency Virus type 1 reverse transcriptase.
February 1996, Biological chemistry Hoppe-Seyler,
H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
Mechanism of resistance to U-90152S and sensitization to L-697,661 by a proline to leucine change at residue 236 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
February 1995, FEBS letters,
H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
January 2004, Molecular pharmacology,
H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
Analysis of mutations at position 184 in reverse transcriptase of human immunodeficiency virus type 1.
July 1995, Antimicrobial agents and chemotherapy,
H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
February 2001, Virology,
H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
Variation of human immunodeficiency virus type-1 reverse transcriptase within the simian immunodeficiency virus genome of RT-SHIV.
January 2014, PloS one,
H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
Anti-human immunodeficiency virus type 1 activities of U-90152 and U-75875 in human brain cell cultures.
October 1994, Antimicrobial agents and chemotherapy,
H Pelemans, and R M Esnouf, and M A Parniak, and A M Vandamme, and E De Clercq, and J Balzarini
HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase.
May 1993, Medicinal research reviews,
Copied contents to your clipboard!